CovidFranceV1, Main, Exploration, bibRecord, 000662

SARS-CoV-2: Virology, epidemiology, immunology and vaccine development.

Identifieur interne : 000662 ( Main/Exploration ); précédent : 000661; suivant : 000663

SARS-CoV-2: Virology, epidemiology, immunology and vaccine development.

Auteurs : Marc Baay [Belgique] ; Bruno Lina [France] ; Arnaud Fontanet [France] ; Arnaud Marchant [Belgique] ; Melanie Saville [Royaume-Uni] ; Philippe Sabot [Suisse] ; Philippe Duclos [Suisse] ; Joris Vandeputte [Suisse] ; Pieter Neels [Suisse]

Source :

Biologicals : journal of the International Association of Biological Standardization [ 1095-8320 ] ; 2020.

RBID : pubmed:32600951

Descripteurs français

KwdFr :
- Adulte (MeSH), Adulte d'âge moyen (MeSH), Betacoronavirus (MeSH), Conception de médicament (MeSH), Congrès comme sujet (MeSH), Coopération internationale (MeSH), Femelle (MeSH), Humains (MeSH), Infections à coronavirus (immunologie), Infections à coronavirus (prévention et contrôle), Infections à coronavirus (virologie), Infections à coronavirus (épidémiologie), Internet (MeSH), Jeune adulte (MeSH), Mâle (MeSH), Normes de référence (MeSH), Pandémies (prévention et contrôle), Pneumopathie virale (immunologie), Pneumopathie virale (prévention et contrôle), Pneumopathie virale (virologie), Pneumopathie virale (épidémiologie), Saisons (MeSH), Santé mondiale (MeSH), Sujet âgé (MeSH), Sujet âgé de 80 ans ou plus (MeSH), Taux de reproduction de base (MeSH), Télécommunications (MeSH), Vaccins antiviraux (MeSH), Virologie (tendances).
MESH :
- immunologie : Infections à coronavirus, Pneumopathie virale.
- prévention et contrôle : Infections à coronavirus, Pandémies, Pneumopathie virale.
- tendances : Virologie.
- virologie : Infections à coronavirus, Pneumopathie virale.
- épidémiologie : Infections à coronavirus, Pneumopathie virale.
- Adulte, Adulte d'âge moyen, Betacoronavirus, Conception de médicament, Congrès comme sujet, Coopération internationale, Femelle, Humains, Internet, Jeune adulte, Mâle, Normes de référence, Saisons, Santé mondiale, Sujet âgé, Sujet âgé de 80 ans ou plus, Taux de reproduction de base, Télécommunications, Vaccins antiviraux.

English descriptors

KwdEn :
- Adult (MeSH), Aged (MeSH), Aged, 80 and over (MeSH), Basic Reproduction Number (MeSH), Betacoronavirus (MeSH), Congresses as Topic (MeSH), Coronavirus Infections (epidemiology), Coronavirus Infections (immunology), Coronavirus Infections (prevention & control), Coronavirus Infections (virology), Drug Design (MeSH), Female (MeSH), Global Health (MeSH), Humans (MeSH), International Cooperation (MeSH), Internet (MeSH), Male (MeSH), Middle Aged (MeSH), Pandemics (prevention & control), Pneumonia, Viral (epidemiology), Pneumonia, Viral (immunology), Pneumonia, Viral (prevention & control), Pneumonia, Viral (virology), Reference Standards (MeSH), Seasons (MeSH), Telecommunications (MeSH), Viral Vaccines (MeSH), Virology (trends), Young Adult (MeSH).
MESH :
- chemical : Viral Vaccines.
- epidemiology : Coronavirus Infections, Pneumonia, Viral.
- immunology : Coronavirus Infections, Pneumonia, Viral.
- prevention & control : Coronavirus Infections, Pandemics, Pneumonia, Viral.
- trends : Virology.
- virology : Coronavirus Infections, Pneumonia, Viral.
- Adult, Aged, Aged, 80 and over, Basic Reproduction Number, Betacoronavirus, Congresses as Topic, Drug Design, Female, Global Health, Humans, International Cooperation, Internet, Male, Middle Aged, Reference Standards, Seasons, Telecommunications, Young Adult.

Abstract

This first International Alliance for Biological Standardization Covid-19 webinar brought together a broad range of international stakeholders, including academia, regulators, funders and industry, with a considerable delegation from low- and middle-income countries, to discuss the virology, epidemiology and immunology of, and the vaccine development for SARS-CoV-2.

DOI: 10.1016/j.biologicals.2020.06.005
PubMed: 32600951
PubMed Central: PMC7309765

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000B62
to stream Main, to step Curation: 000B62

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">SARS-CoV-2: Virology, epidemiology, immunology and vaccine development.</title>
<author><name sortKey="Baay, Marc" sort="Baay, Marc" uniqKey="Baay M" first="Marc" last="Baay">Marc Baay</name>
<affiliation wicri:level="1"><nlm:affiliation>P95 Epidemiology & Pharmacovigilance, Leuven, Belgium. Electronic address: marc.baay@p-95.com.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>P95 Epidemiology & Pharmacovigilance, Leuven</wicri:regionArea>
<wicri:noRegion>Leuven</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lina, Bruno" sort="Lina, Bruno" uniqKey="Lina B" first="Bruno" last="Lina">Bruno Lina</name>
<affiliation wicri:level="3"><nlm:affiliation>University Claude Bernard Lyon, VirPath Research Laboratory, Lyon, France. Electronic address: bruno.lina@univ-lyon1.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>University Claude Bernard Lyon, VirPath Research Laboratory, Lyon</wicri:regionArea>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fontanet, Arnaud" sort="Fontanet, Arnaud" uniqKey="Fontanet A" first="Arnaud" last="Fontanet">Arnaud Fontanet</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Global Health, Emerging Diseases Epidemiology Unit, Institut Pasteur, Paris, France. Electronic address: arnaud.fontanet@pasteur.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Global Health, Emerging Diseases Epidemiology Unit, Institut Pasteur, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Marchant, Arnaud" sort="Marchant, Arnaud" uniqKey="Marchant A" first="Arnaud" last="Marchant">Arnaud Marchant</name>
<affiliation wicri:level="4"><nlm:affiliation>Institute for Medical Immunology, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: arnaud.marchant@ulb.be.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Institute for Medical Immunology, Université Libre de Bruxelles, Brussels</wicri:regionArea>
<placeName><settlement type="city">Bruxelles</settlement>
<region nuts="2">Région de Bruxelles-Capitale</region>
</placeName>
<orgName type="university">Université libre de Bruxelles</orgName>
</affiliation>
</author>
<author><name sortKey="Saville, Melanie" sort="Saville, Melanie" uniqKey="Saville M" first="Melanie" last="Saville">Melanie Saville</name>
<affiliation wicri:level="3"><nlm:affiliation>Vaccine R&D, CEPI Vaccines, London, UK. Electronic address: melanie.saville@cepi.net.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Vaccine R&D, CEPI Vaccines, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sabot, Philippe" sort="Sabot, Philippe" uniqKey="Sabot P" first="Philippe" last="Sabot">Philippe Sabot</name>
<affiliation wicri:level="1"><nlm:affiliation>International Alliance for Biological Standardization - IABS, Geneva, Switzerland. Electronic address: philippe.sabot@iabs.org.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>International Alliance for Biological Standardization - IABS, Geneva</wicri:regionArea>
<wicri:noRegion>Geneva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Duclos, Philippe" sort="Duclos, Philippe" uniqKey="Duclos P" first="Philippe" last="Duclos">Philippe Duclos</name>
<affiliation wicri:level="4"><nlm:affiliation>ADVAC, University of Geneva, Geneva, Switzerland. Electronic address: Philippe.Duclos@unige.ch.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>ADVAC, University of Geneva, Geneva</wicri:regionArea>
<orgName type="university">Université de Genève</orgName>
<placeName><settlement type="city">Genève</settlement>
<region nuts="3" type="region">Canton de Genève</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vandeputte, Joris" sort="Vandeputte, Joris" uniqKey="Vandeputte J" first="Joris" last="Vandeputte">Joris Vandeputte</name>
<affiliation wicri:level="1"><nlm:affiliation>International Alliance for Biological Standardization - IABS, Geneva, Switzerland. Electronic address: joris.vandeputte@iabs.org.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>International Alliance for Biological Standardization - IABS, Geneva</wicri:regionArea>
<wicri:noRegion>Geneva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Neels, Pieter" sort="Neels, Pieter" uniqKey="Neels P" first="Pieter" last="Neels">Pieter Neels</name>
<affiliation wicri:level="1"><nlm:affiliation>International Alliance for Biological Standardization - IABS, Geneva, Switzerland. Electronic address: Pieter.neels@vaccine-advice.be.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>International Alliance for Biological Standardization - IABS, Geneva</wicri:regionArea>
<wicri:noRegion>Geneva</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32600951</idno>
<idno type="pmid">32600951</idno>
<idno type="doi">10.1016/j.biologicals.2020.06.005</idno>
<idno type="pmc">PMC7309765</idno>
<idno type="wicri:Area/Main/Corpus">000B62</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000B62</idno>
<idno type="wicri:Area/Main/Curation">000B62</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000B62</idno>
<idno type="wicri:Area/Main/Exploration">000B62</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">SARS-CoV-2: Virology, epidemiology, immunology and vaccine development.</title>
<author><name sortKey="Baay, Marc" sort="Baay, Marc" uniqKey="Baay M" first="Marc" last="Baay">Marc Baay</name>
<affiliation wicri:level="1"><nlm:affiliation>P95 Epidemiology & Pharmacovigilance, Leuven, Belgium. Electronic address: marc.baay@p-95.com.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>P95 Epidemiology & Pharmacovigilance, Leuven</wicri:regionArea>
<wicri:noRegion>Leuven</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lina, Bruno" sort="Lina, Bruno" uniqKey="Lina B" first="Bruno" last="Lina">Bruno Lina</name>
<affiliation wicri:level="3"><nlm:affiliation>University Claude Bernard Lyon, VirPath Research Laboratory, Lyon, France. Electronic address: bruno.lina@univ-lyon1.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>University Claude Bernard Lyon, VirPath Research Laboratory, Lyon</wicri:regionArea>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fontanet, Arnaud" sort="Fontanet, Arnaud" uniqKey="Fontanet A" first="Arnaud" last="Fontanet">Arnaud Fontanet</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Global Health, Emerging Diseases Epidemiology Unit, Institut Pasteur, Paris, France. Electronic address: arnaud.fontanet@pasteur.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Global Health, Emerging Diseases Epidemiology Unit, Institut Pasteur, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Marchant, Arnaud" sort="Marchant, Arnaud" uniqKey="Marchant A" first="Arnaud" last="Marchant">Arnaud Marchant</name>
<affiliation wicri:level="4"><nlm:affiliation>Institute for Medical Immunology, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: arnaud.marchant@ulb.be.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Institute for Medical Immunology, Université Libre de Bruxelles, Brussels</wicri:regionArea>
<placeName><settlement type="city">Bruxelles</settlement>
<region nuts="2">Région de Bruxelles-Capitale</region>
</placeName>
<orgName type="university">Université libre de Bruxelles</orgName>
</affiliation>
</author>
<author><name sortKey="Saville, Melanie" sort="Saville, Melanie" uniqKey="Saville M" first="Melanie" last="Saville">Melanie Saville</name>
<affiliation wicri:level="3"><nlm:affiliation>Vaccine R&D, CEPI Vaccines, London, UK. Electronic address: melanie.saville@cepi.net.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Vaccine R&D, CEPI Vaccines, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sabot, Philippe" sort="Sabot, Philippe" uniqKey="Sabot P" first="Philippe" last="Sabot">Philippe Sabot</name>
<affiliation wicri:level="1"><nlm:affiliation>International Alliance for Biological Standardization - IABS, Geneva, Switzerland. Electronic address: philippe.sabot@iabs.org.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>International Alliance for Biological Standardization - IABS, Geneva</wicri:regionArea>
<wicri:noRegion>Geneva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Duclos, Philippe" sort="Duclos, Philippe" uniqKey="Duclos P" first="Philippe" last="Duclos">Philippe Duclos</name>
<affiliation wicri:level="4"><nlm:affiliation>ADVAC, University of Geneva, Geneva, Switzerland. Electronic address: Philippe.Duclos@unige.ch.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>ADVAC, University of Geneva, Geneva</wicri:regionArea>
<orgName type="university">Université de Genève</orgName>
<placeName><settlement type="city">Genève</settlement>
<region nuts="3" type="region">Canton de Genève</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vandeputte, Joris" sort="Vandeputte, Joris" uniqKey="Vandeputte J" first="Joris" last="Vandeputte">Joris Vandeputte</name>
<affiliation wicri:level="1"><nlm:affiliation>International Alliance for Biological Standardization - IABS, Geneva, Switzerland. Electronic address: joris.vandeputte@iabs.org.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>International Alliance for Biological Standardization - IABS, Geneva</wicri:regionArea>
<wicri:noRegion>Geneva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Neels, Pieter" sort="Neels, Pieter" uniqKey="Neels P" first="Pieter" last="Neels">Pieter Neels</name>
<affiliation wicri:level="1"><nlm:affiliation>International Alliance for Biological Standardization - IABS, Geneva, Switzerland. Electronic address: Pieter.neels@vaccine-advice.be.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>International Alliance for Biological Standardization - IABS, Geneva</wicri:regionArea>
<wicri:noRegion>Geneva</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Biologicals : journal of the International Association of Biological Standardization</title>
<idno type="eISSN">1095-8320</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Aged, 80 and over (MeSH)</term>
<term>Basic Reproduction Number (MeSH)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Congresses as Topic (MeSH)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Coronavirus Infections (immunology)</term>
<term>Coronavirus Infections (prevention & control)</term>
<term>Coronavirus Infections (virology)</term>
<term>Drug Design (MeSH)</term>
<term>Female (MeSH)</term>
<term>Global Health (MeSH)</term>
<term>Humans (MeSH)</term>
<term>International Cooperation (MeSH)</term>
<term>Internet (MeSH)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Pandemics (prevention & control)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>Pneumonia, Viral (immunology)</term>
<term>Pneumonia, Viral (prevention & control)</term>
<term>Pneumonia, Viral (virology)</term>
<term>Reference Standards (MeSH)</term>
<term>Seasons (MeSH)</term>
<term>Telecommunications (MeSH)</term>
<term>Viral Vaccines (MeSH)</term>
<term>Virology (trends)</term>
<term>Young Adult (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Conception de médicament (MeSH)</term>
<term>Congrès comme sujet (MeSH)</term>
<term>Coopération internationale (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Infections à coronavirus (immunologie)</term>
<term>Infections à coronavirus (prévention et contrôle)</term>
<term>Infections à coronavirus (virologie)</term>
<term>Infections à coronavirus (épidémiologie)</term>
<term>Internet (MeSH)</term>
<term>Jeune adulte (MeSH)</term>
<term>Mâle (MeSH)</term>
<term>Normes de référence (MeSH)</term>
<term>Pandémies (prévention et contrôle)</term>
<term>Pneumopathie virale (immunologie)</term>
<term>Pneumopathie virale (prévention et contrôle)</term>
<term>Pneumopathie virale (virologie)</term>
<term>Pneumopathie virale (épidémiologie)</term>
<term>Saisons (MeSH)</term>
<term>Santé mondiale (MeSH)</term>
<term>Sujet âgé (MeSH)</term>
<term>Sujet âgé de 80 ans ou plus (MeSH)</term>
<term>Taux de reproduction de base (MeSH)</term>
<term>Télécommunications (MeSH)</term>
<term>Vaccins antiviraux (MeSH)</term>
<term>Virologie (tendances)</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pandemics</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pandémies</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="tendances" xml:lang="fr"><term>Virologie</term>
</keywords>
<keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Virology</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Basic Reproduction Number</term>
<term>Betacoronavirus</term>
<term>Congresses as Topic</term>
<term>Drug Design</term>
<term>Female</term>
<term>Global Health</term>
<term>Humans</term>
<term>International Cooperation</term>
<term>Internet</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Reference Standards</term>
<term>Seasons</term>
<term>Telecommunications</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Betacoronavirus</term>
<term>Conception de médicament</term>
<term>Congrès comme sujet</term>
<term>Coopération internationale</term>
<term>Femelle</term>
<term>Humains</term>
<term>Internet</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Normes de référence</term>
<term>Saisons</term>
<term>Santé mondiale</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Taux de reproduction de base</term>
<term>Télécommunications</term>
<term>Vaccins antiviraux</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">This first International Alliance for Biological Standardization Covid-19 webinar brought together a broad range of international stakeholders, including academia, regulators, funders and industry, with a considerable delegation from low- and middle-income countries, to discuss the virology, epidemiology and immunology of, and the vaccine development for SARS-CoV-2.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32600951</PMID>
<DateCompleted><Year>2020</Year>
<Month>08</Month>
<Day>06</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>08</Month>
<Day>06</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-8320</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>66</Volume>
<PubDate><Year>2020</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Biologicals : journal of the International Association of Biological Standardization</Title>
<ISOAbbreviation>Biologicals</ISOAbbreviation>
</Journal>
<ArticleTitle>SARS-CoV-2: Virology, epidemiology, immunology and vaccine development.</ArticleTitle>
<Pagination><MedlinePgn>35-40</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S1045-1056(20)30066-X</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biologicals.2020.06.005</ELocationID>
<Abstract><AbstractText>This first International Alliance for Biological Standardization Covid-19 webinar brought together a broad range of international stakeholders, including academia, regulators, funders and industry, with a considerable delegation from low- and middle-income countries, to discuss the virology, epidemiology and immunology of, and the vaccine development for SARS-CoV-2.</AbstractText>
<CopyrightInformation>Copyright © 2020. Published by Elsevier Ltd.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Baay</LastName>
<ForeName>Marc</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>P95 Epidemiology & Pharmacovigilance, Leuven, Belgium. Electronic address: marc.baay@p-95.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lina</LastName>
<ForeName>Bruno</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>University Claude Bernard Lyon, VirPath Research Laboratory, Lyon, France. Electronic address: bruno.lina@univ-lyon1.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Fontanet</LastName>
<ForeName>Arnaud</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Global Health, Emerging Diseases Epidemiology Unit, Institut Pasteur, Paris, France. Electronic address: arnaud.fontanet@pasteur.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Marchant</LastName>
<ForeName>Arnaud</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Institute for Medical Immunology, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: arnaud.marchant@ulb.be.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Saville</LastName>
<ForeName>Melanie</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Vaccine R&D, CEPI Vaccines, London, UK. Electronic address: melanie.saville@cepi.net.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sabot</LastName>
<ForeName>Philippe</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>International Alliance for Biological Standardization - IABS, Geneva, Switzerland. Electronic address: philippe.sabot@iabs.org.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Duclos</LastName>
<ForeName>Philippe</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>ADVAC, University of Geneva, Geneva, Switzerland. Electronic address: Philippe.Duclos@unige.ch.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Vandeputte</LastName>
<ForeName>Joris</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>International Alliance for Biological Standardization - IABS, Geneva, Switzerland. Electronic address: joris.vandeputte@iabs.org.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Neels</LastName>
<ForeName>Pieter</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>International Alliance for Biological Standardization - IABS, Geneva, Switzerland. Electronic address: Pieter.neels@vaccine-advice.be.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym>
<Agency>Wellcome Trust</Agency>
<Country>United Kingdom</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>06</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Biologicals</MedlineTA>
<NlmUniqueID>9004494</NlmUniqueID>
<ISSNLinking>1045-1056</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C000669933">COVID-19 vaccine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D050936" MajorTopicYN="N">Basic Reproduction Number</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003226" MajorTopicYN="N">Congresses as Topic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015195" MajorTopicYN="N">Drug Design</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007391" MajorTopicYN="N">International Cooperation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D020407" MajorTopicYN="N">Internet</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012015" MajorTopicYN="N">Reference Standards</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013685" MajorTopicYN="N">Telecommunications</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014765" MajorTopicYN="Y">Viral Vaccines</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014773" MajorTopicYN="N">Virology</DescriptorName>
<QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Epidemiology</Keyword>
<Keyword MajorTopicYN="N">Immunology</Keyword>
<Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
<Keyword MajorTopicYN="N">Vaccine development</Keyword>
<Keyword MajorTopicYN="N">Virology</Keyword>
</KeywordList>
<CoiStatement>Declaration of competing interest The authors have no competing interests to declare.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>06</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>06</Month>
<Day>19</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>7</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>8</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>7</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32600951</ArticleId>
<ArticleId IdType="pii">S1045-1056(20)30066-X</ArticleId>
<ArticleId IdType="doi">10.1016/j.biologicals.2020.06.005</ArticleId>
<ArticleId IdType="pmc">PMC7309765</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Belgique</li>
<li>France</li>
<li>Royaume-Uni</li>
<li>Suisse</li>
</country>
<region><li>Angleterre</li>
<li>Auvergne-Rhône-Alpes</li>
<li>Canton de Genève</li>
<li>Grand Londres</li>
<li>Rhône-Alpes</li>
<li>Région de Bruxelles-Capitale</li>
<li>Île-de-France</li>
</region>
<settlement><li>Bruxelles</li>
<li>Genève</li>
<li>Londres</li>
<li>Lyon</li>
<li>Paris</li>
</settlement>
<orgName><li>Université de Genève</li>
<li>Université libre de Bruxelles</li>
</orgName>
</list>
<tree><country name="Belgique"><noRegion><name sortKey="Baay, Marc" sort="Baay, Marc" uniqKey="Baay M" first="Marc" last="Baay">Marc Baay</name>
</noRegion>
<name sortKey="Marchant, Arnaud" sort="Marchant, Arnaud" uniqKey="Marchant A" first="Arnaud" last="Marchant">Arnaud Marchant</name>
</country>
<country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="Lina, Bruno" sort="Lina, Bruno" uniqKey="Lina B" first="Bruno" last="Lina">Bruno Lina</name>
</region>
<name sortKey="Fontanet, Arnaud" sort="Fontanet, Arnaud" uniqKey="Fontanet A" first="Arnaud" last="Fontanet">Arnaud Fontanet</name>
</country>
<country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Saville, Melanie" sort="Saville, Melanie" uniqKey="Saville M" first="Melanie" last="Saville">Melanie Saville</name>
</region>
</country>
<country name="Suisse"><noRegion><name sortKey="Sabot, Philippe" sort="Sabot, Philippe" uniqKey="Sabot P" first="Philippe" last="Sabot">Philippe Sabot</name>
</noRegion>
<name sortKey="Duclos, Philippe" sort="Duclos, Philippe" uniqKey="Duclos P" first="Philippe" last="Duclos">Philippe Duclos</name>
<name sortKey="Neels, Pieter" sort="Neels, Pieter" uniqKey="Neels P" first="Pieter" last="Neels">Pieter Neels</name>
<name sortKey="Vandeputte, Joris" sort="Vandeputte, Joris" uniqKey="Vandeputte J" first="Joris" last="Vandeputte">Joris Vandeputte</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000662 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000662 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32600951
   |texte=   SARS-CoV-2: Virology, epidemiology, immunology and vaccine development.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32600951" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidFranceV1

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021

	Serveur d'exploration sur la COVID en France
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur la COVID en France

SARS-CoV-2: Virology, epidemiology, immunology and vaccine development.

SARS-CoV-2: Virology, epidemiology, immunology and vaccine development.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki